Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 5/2013

01-10-2013 | Original Article

An algorithm for the management of Staphylococcus aureus carriage within patients with recurrent staphylococcal skin infections

Authors: Fotios Tzermpos, Theodora Kanni, Vassiliki Tzanetakou, Christos Papadimas, Anastasia Antonopoulou, Athina Savva, Nadia Theologie-Lygidakis, Evangelos J. Giamarellos-Bourboulis

Published in: Journal of Infection and Chemotherapy | Issue 5/2013

Login to get access

Abstract

Recurrent skin infections of staphylococcal origin raise the question of probable skin colonization by Staphylococcus aureus and the need for eradication. Available evidence does not exist for such settings. A management algorithm was developed by a group of experts that was implemented prospectively in 125 patients admitted for recurrent staphylococcal skin infections. Patients were tested for skin carriage of S. aureus in seven body surfaces. In the event of carriage, therapy was administered consisting of hair and body washing with antiseptics for 60 days and parallel oral treatment according to the antibiogram for 30 days. Patients were followed up for 3 years. Seventy-nine patients were colonized by S. aureus, 49 by methicillin-susceptible (MSSA) and 30 by methicillin-resistant (MRSA) isolates. The eradication rate following the algorithm was 83.7 % for patients colonized by MSSA and 90.0 % for patients colonized by MRSA. The greater eradication rates were achieved after treatment with one antistaphylococcal penicillin or clindamycin in the case of MSSA carriage and with clindamycin or a fluoroquinolone in the case of MRSA carriage. Of the 79 treated cases, 18 relapsed. Time to relapse did not differ between MSSA carriers and MRSA carriers. It is concluded that the suggested algorithm may be clinically efficacious and achieve high decolonization and low relapse within patients with recurrent staphylococcal skin infections colonized by either MSSA or MRSA.
Literature
1.
go back to reference Stevens AM, Hennessey T, Baggett HC, Bruden D, Parks D, Klejka J. Methicillin-resistant Staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, USA. Emerg Infect Dis. 2010;16:797–802.PubMed Stevens AM, Hennessey T, Baggett HC, Bruden D, Parks D, Klejka J. Methicillin-resistant Staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, USA. Emerg Infect Dis. 2010;16:797–802.PubMed
2.
go back to reference Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin R, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus eradication. Clin Infect Dis. 2007;44:178–85.PubMedCrossRef Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin R, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus eradication. Clin Infect Dis. 2007;44:178–85.PubMedCrossRef
3.
go back to reference Ammerlaan HSM, Kluytmans JAJW, Berkout H, Buiting A, de Brauwer EIGB, et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother. 2011;66:2409–17.PubMedCrossRef Ammerlaan HSM, Kluytmans JAJW, Berkout H, Buiting A, de Brauwer EIGB, et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother. 2011;66:2409–17.PubMedCrossRef
4.
go back to reference Ammerlaan HSM, Luytmans JAJW, Wertheim HFL, Nouwen JL, Bonten MJM. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systemic review. Clin Infect Dis. 2009;48:922–30.PubMedCrossRef Ammerlaan HSM, Luytmans JAJW, Wertheim HFL, Nouwen JL, Bonten MJM. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systemic review. Clin Infect Dis. 2009;48:922–30.PubMedCrossRef
5.
go back to reference Stryjweski ME, Graham DR, Wilson SE, O’Riordain W, Young D, Lentnek A, et al. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis. 2008;46:1683–93.CrossRef Stryjweski ME, Graham DR, Wilson SE, O’Riordain W, Young D, Lentnek A, et al. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis. 2008;46:1683–93.CrossRef
6.
go back to reference Mollema FPN, Severin JA, Nouwen JL, Ott A, Verugh HA, Vos MC. Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother. 2010;54:4020–5.PubMedCrossRef Mollema FPN, Severin JA, Nouwen JL, Ott A, Verugh HA, Vos MC. Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother. 2010;54:4020–5.PubMedCrossRef
7.
go back to reference Fernandes CJ, Fernandes LA, Collignon P. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2005;55:506–510. Fernandes CJ, Fernandes LA, Collignon P. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2005;55:506–510.
8.
go back to reference Demos M, McLeod MP, Nouri K. Recurrent furunculosis: a review of the literature. Br J Dermatol. 2012;167:725–32.PubMedCrossRef Demos M, McLeod MP, Nouri K. Recurrent furunculosis: a review of the literature. Br J Dermatol. 2012;167:725–32.PubMedCrossRef
9.
go back to reference Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–72.PubMed Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–72.PubMed
10.
go back to reference Costelloe C, Lovering A, Montgomery A, Lewis D, McNulty C, Hay AD. Effect of antibiotic prescribing in primary care on methicillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study. Int J Antimicrob Agents. 2012;39:135–41.PubMedCrossRef Costelloe C, Lovering A, Montgomery A, Lewis D, McNulty C, Hay AD. Effect of antibiotic prescribing in primary care on methicillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study. Int J Antimicrob Agents. 2012;39:135–41.PubMedCrossRef
11.
go back to reference Daeschlein G, Assadian O, Rangous I, Kramer A. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect. 2006;63:216–20.PubMedCrossRef Daeschlein G, Assadian O, Rangous I, Kramer A. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect. 2006;63:216–20.PubMedCrossRef
12.
go back to reference Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vaincent C, et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings. Arch Intern Med. 2009;169:1372–8.PubMedCrossRef Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vaincent C, et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings. Arch Intern Med. 2009;169:1372–8.PubMedCrossRef
13.
go back to reference Zanger P, Nurjadi D, Vath B, Kremsner PG. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human β-defensin 3 after sterile wounding of healthy skin in vivo. Infect Immun. 2011;79:2658–62.PubMedCrossRef Zanger P, Nurjadi D, Vath B, Kremsner PG. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human β-defensin 3 after sterile wounding of healthy skin in vivo. Infect Immun. 2011;79:2658–62.PubMedCrossRef
Metadata
Title
An algorithm for the management of Staphylococcus aureus carriage within patients with recurrent staphylococcal skin infections
Authors
Fotios Tzermpos
Theodora Kanni
Vassiliki Tzanetakou
Christos Papadimas
Anastasia Antonopoulou
Athina Savva
Nadia Theologie-Lygidakis
Evangelos J. Giamarellos-Bourboulis
Publication date
01-10-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 5/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-013-0564-2

Other articles of this Issue 5/2013

Journal of Infection and Chemotherapy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine